Back
Edgewise Therapeutics Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
55
EWTX
Edgewise Therapeutics
Last Price:
29.45
Seasonality Move:
50.24%
Sell
42
SRPT
Sarepta Therapeutics
Last Price:
126.71
Seasonality Move:
11.15%
Buy
55
Edgewise Therapeutics (EWTX)
is a Buy
Is Edgewise Therapeutics a Buy, Sell or Hold?
- The current Edgewise Therapeutics [EWTX] share price is $29.46. The Score for EWTX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- EWTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $126.70. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EWTX Stock Price Chart
What is Edgewise Therapeutics's stock price today?
-
The Edgewise Therapeutics share price today is $29.46
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EWTX is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $126.70
The current trend is moderately bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
EWTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.42 | Sell |
| Relative Strength Index (14 RSI): | 37.2 | Sell |
| Chaikin Money Flow: | -252919 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.89 - 34.67) | Sell |
| Bollinger Bands (100): | (18.81 - 33.01) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.07 | Buy |
| Relative Strength Index (14 RSI): | 54.46 | Buy |
| Chaikin Money Flow: | -283343 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (110.96 - 129.62) | Buy |
| Bollinger Bands (100): | (118.96 - 138.82) | Sell |
EWTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.55 | Sell |
| 20-day SMA: | 32 | Sell |
| 50-day SMA: | 32.34 | Sell |
| 200-day SMA: | 21.84 | Buy |
| 8-day EMA: | 31.22 | Sell |
| 20-day EMA: | 31.94 | Sell |
| 50-day EMA: | 30.81 | Sell |
| 200-day EMA: | 23.03 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 128 | Sell |
| 20-day SMA: | 119.72 | Buy |
| 50-day SMA: | 122.58 | Buy |
| 200-day SMA: | 129.92 | Sell |
| 8-day EMA: | 126.76 | Sell |
| 20-day EMA: | 123.91 | Buy |
| 50-day EMA: | 124.01 | Buy |
| 200-day EMA: | 126.24 | Buy |
Edgewise Therapeutics Earnings Growth & EWTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and a decrease next year of $0.34 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.77 per share, and an increase next year of $7.82 per share.
Edgewise Therapeutics Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||